Acai Berry Living-XS Diet capsules

Safety advisory

10 January 2014

Acai Berry Living-XS Diet capsules pose a serious risk to your health and should not be taken.

The Therapeutic Goods Administration (TGA) has tested Acai Berry Living-XS Diet capsules and found that:

  • Acai Berry packagingit contains the undeclared prescription substance sibutramine - despite the product label claim that it is natural and contains no medicines.
  • consumers are advised that sibutramine is a prescription-only substance (which was the active ingredient in the medicine Reductil). It was withdrawn in October 2010 after a study showed an increased risk of major cardiac events.
  • the levels of sibutramine found in these capsules is above the previously allowable prescription levels.
  • it also contains the undeclared substance phenolphthalein which was previously used as an oral laxative, but is no longer available in Australia due to serious safety concerns associated with its long term use.

The supply of Acai Berry Living-XS Diet capsules is illegal.

Acai Berry bottleAcai Berry Living-XS Diet capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.

TGA investigations have shown that people in Australia may have bought the product online.

Information for consumers

  • Stop taking Acai Berry Living-XS Diet capsules and take any remaining capsules to your local pharmacy for safe disposal.
  • If you have any concerns arising from your use of this product, consult your health care practitioner.

Action the TGA is taking

The TGA is working with Australian Customs and Border Protection Services (Customs) to help stop future shipments of Acai Berry Living-XS Diet capsules from entering Australia.

If these capsules are found at the border by Customs they will be seized and destroyed.

The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites. Products purchased over the Internet:

  • may contain undisclosed and potentially harmful ingredients
  • may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.

Report counterfeit medicines and medical devices

If you are worried about counterfeit medicines or medical devices, and want to report an issue, you can report the matter to the TGA:

Phone: 1800 020 653
Online: Report a perceived breach of the Therapeutic Goods Act or questionable practices relating to therapeutic products
Email: info@tga.gov.au